Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.

BMJ (Clinical research ed.)·2026

Same author

Exposure to multiple metallic elements and risk of thyroid tumors: insights from elemental profiling, diet, and molecular characteristics plasma levels of metallic elements.

Frontiers in oncology·2026

Same author

Machine Learning Multiorgan Analysis of Coronary CT Angiography Body Composition, Myocardial Infarction, and Mortality in the SCOT-HEART Trial.

Radiology·2026

Same author

Supratopological Ion-Coordinated Binder Networks for Durable and Kinetically Efficient Silicon Anodes.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Urea cycle dysregulation and arginine pathways in the pathogenesis of NAFLD and NASH (Review).

International journal of molecular medicine·2026

Same author

Rare <i>BRCA1</i> c.3418_3419insTGACTACT:p.S1140Mfs*18 germline mutation in a family with breast and ovarian cancer.

Oncology letters·2026

Search research articles

Related Experiment Video

Updated: Jun 25, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Multiple primary lung cancer: Updates and perspectives.

Ziqi Wang^1,2, Quncheng Zhang^1,2, Chaoyang Wang^1,2

¹Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.

International Journal of Cancer

|May 24, 2024

Summary

Managing multiple primary lung cancer (MPLC) is complex due to rising incidence and diagnostic challenges. This review explores molecular characteristics, diagnostics, and treatments for MPLC, offering insights for future research.

Keywords:

etiology management multiple primary lung cancer next‐generation sequencing

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Related Experiment Videos

Last Updated: Jun 25, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Area of Science:

Oncology
Pulmonology
Medical Imaging

Background:

Multiple primary lung cancer (MPLC) incidence is increasing, particularly with advances in low-dose computed tomography screening detecting more lung nodules.
The pathogenesis, diagnostic criteria, and treatment selection for MPLC present significant clinical challenges.
Understanding MPLC is crucial for improving patient outcomes.

Purpose of the Study:

To review current knowledge on the molecular characteristics of MPLC.
To explore novel diagnostic approaches and emerging treatment modalities for MPLC.
To provide insights and inspire future research in MPLC management.

Main Methods:

Literature review focusing on recent advancements in MPLC research.
Analysis of studies dissecting molecular features of MPLC.
Examination of new diagnostic and therapeutic strategies for MPLC.

Main Results:

Emerging evidence highlights the importance of molecular profiling in MPLC.
New diagnostic tools are being developed to better differentiate MPLC from intrapulmonary metastases.
Innovative treatment strategies are under investigation, including targeted therapies and immunotherapy.

Conclusions:

Effective management of MPLC requires a comprehensive understanding of its molecular landscape.
Continued research into diagnostics and treatments is essential for advancing MPLC care.
This review synthesizes current evidence to guide future clinical practice and research endeavors in MPLC.